January 23, 2020
Last year, our client, the Pulmonary Fibrosis Foundation (PFF), issued a position statement warning patients and providers against the dangers of unregulated stem cell therapies that often promise miraculous results but come with significant health risks. We pitched the statement to national media, and were happy to connect PFF’s Chief Medical Officer, Dr. Gregory Cosgrove, with a Washington Post reporter investigating the topic. Several months and conversations later, a front-page Washington Post article ran to educate readers of the hazards of unproven stem cell therapies, alongside an investigation into one organization offering these dangerous treatments.
While some stem cell treatments have been approved for other disease states, we hope this high-profile placement will drive awareness of the potential dangers of stem cell therapies for PF that are not part of regulated clinical trials.